2nd Fluid and Imaging Biomarkers and Endpoints in Neuroscience Summit 2024
Evvnt Promotion / evvnt
Archivio
22.10.2024 - 24.10.2024 The Colonnade Hotel, 120 Huntington Avenue, 02116 Boston, Massachusetts, USA
Time: 8:00 AM - 5:00 PM
Temi della conferenza
Accelerating More Sensitive, Quantitative and Predictive Serological and Imaging Biomarkers to Transform Clinical Development in the CNS.
With the Donanemab ADCOM hailing fluid biomarkers as a deciding factor in the unanimous decision, improved plasma ptau 217 markers and PET tracers, and α-syn self-seeding assay sensitivity and enhancing NFL utility beyond SOD-1 ALS, 2024 has opened the floodgates for biomarker innovation.
Accelerating More Sensitive, Quantitative and Predictive Serological and Imaging Biomarkers to Transform Clinical Development in the CNS.
With the Donanemab ADCOM hailing fluid biomarkers as a deciding factor in the unanimous decision, improved plasma ptau 217 markers and PET tracers, and α-syn self-seeding assay sensitivity and enhancing NFL utility beyond SOD-1 ALS, 2024 has opened the floodgates for biomarker innovation.
Professional congress organizer (PCO)
Hanson Wade
Hanson Wade
Annotazioni
URL:
Brochure: https://go.evvnt.com/2542184-3?pid=4832
Speakers: Aarti Narang, Biomarker Clinical Assay Lead, Pfizer, Bradford Navia, Chief Medical Officer, Aprinoia Therapeutics Inc., and more
URL:
Brochure: https://go.evvnt.com/2542184-3?pid=4832
Speakers: Aarti Narang, Biomarker Clinical Assay Lead, Pfizer, Bradford Navia, Chief Medical Officer, Aprinoia Therapeutics Inc., and more
Informazioni ed Iscrizioni:
https://go.evvnt.com/2542184-2?pid=4832
Ms. Erin Thomas
Medicina General
Contatto organizzatori
83 Great Titchfield Street
W1W 6RH London
United Kingdom
83 Great Titchfield Street
W1W 6RH London
United Kingdom
"Noi, Going International, siamo un’azienda che si è scelta come obiettivo di rendere acessibile la formazione a una grandissima quantità di persone, oltrepassanddo i confini geografici e sociali."
